Immunohistochemical tests diagnose the causes of resistance associated with SCLC transformation (expression of CD56, Ki-67, neuroendocrine markers on cancer cells) [55,56] and epithelial to mesenchymal transition (EMT) [57]. This evidence concerns the gene NCAM1 and cancer.